Vitamins K1 and K2: the emerging group of vitamins required for human health (Schwalfenberg GK)

A Canadian researcher sought to review the evidence for the use of vitamin K supplementation in clinical conditions such as osteoporosis, vascular calcification, arthritis, cancer, renal calculi, diabetes, and warfarin therapy. His findings were published as a review in the Journal of Nutrition and Metabolism.

PubMed was searched for articles on vitamin K (K1 and K2) along with books and conference proceedings and health conditions listed above. Level I and II evidence supports the use of vitamins K1 and K2 in osteoporosis and Level II evidence supports vitamin K2 in prevention of coronary calcification and cardiovascular disease, but the researcher expressed that current evidence is insufficient for use in diabetes, arthritis, renal calculi, and cancer.

Vitamin K2 may be a useful adjunct for the treatment of osteoporosis, along with vitamin D and calcium, rivaling bisphosphonate therapy without toxicity, according to the review. It may also significantly reduce morbidity and mortality in cardiovascular health by reducing vascular calcification. Vitamin K2 appears promising in the areas of diabetes, cancer, and osteoarthritis. Vitamin K use in warfarin therapy is safe and may improve INR control, although a dosage adjustment is required.

The author concluded: “Vitamin K supplementation may be useful for a number of chronic conditions that are afflicting North Americans as the population ages. Supplementation may be required for bone and cardiovascular health.”

 

Reference:

Schwalfenberg GK. Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. Journal of Nutrition and Metabolism. Volume 2017, Article ID 6254836. https://doi.org/10.1155/2017/6254836.

x
Recommendation was sent. Thank you!